GNH USA

Europe — EMA

Onkotrone (Mitoxantrone Hydrochloride)

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is an anthracene anthracenedione presented as a unknown/unknown for unknown use. It treats certain cancers and is used in adult oncology patients.

Request sourcing

1
Pack/s

What is Mitoxantrone Hydrochloride?

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is an anthracene anthracenedione presented as a unknown/unknown for unknown use. It treats certain cancers and is used in adult oncology patients.

GNH USA supplies Onkotrone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Mitoxantrone Hydrochloride used for?

Mitoxanone          ...  ...  ...  ... ...  ... ....  ... .... ...  

What are the side effects of Mitoxantrone Hydrochloride?

Common   

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mitoxantrone Hydrochloride
Route
Intravenous Use
Manufacturer
Baxter S.P.A.
Origin
EU

Related products